Earnings are out
Mesoblast (ADR)
Develops FDA-approved Ryoncil for pediatric steroid-refractory acute graft-versus-host disease.
$17.44
After-hours close−0.03 (−0.17%)
At close$17.47(−3.91%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.11 | −$0.13 | −23.2% |
| Feb 2026 | −$0.24 | −$0.31 | −31.2% |
| Sep 2025 | −$0.37 | −$0.21 | +43.0% |
| Apr 2025 | — | −$0.21 | — |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Dec 2015 | |||
| Aug 2015 | |||
| Mar 2015 | |||
| Feb 2015 | |||
| Sep 2014 | |||
| Aug 2014 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | −$0.11 | −$0.13 | −23.2% | $67.0M | $69.0M | +3.0% |
| Feb 26, 2026 | −$0.24 | −$0.31 | −31.2% | $53.1M | $51.3M | −3.2% |
| Sep 3, 2025 | −$0.37 | −$0.21 | +43.0% | $30.7M | $7.0M | −77.1% |
| Apr 30, 2025 | — | −$0.21 | — | $7.5M | $7.0M | −6.2% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | ||||||
| Feb 26, 2025 | ||||||
| Oct 30, 2024 | ||||||
| Jul 4, 2024 | ||||||
| Mar 25, 2024 | ||||||
| Dec 26, 2023 | ||||||
| Aug 30, 2023 | ||||||
| May 25, 2023 | ||||||
| Feb 27, 2023 | ||||||
| Nov 22, 2022 | ||||||
| Aug 30, 2022 | ||||||
| May 31, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 23, 2021 | ||||||
| Aug 31, 2021 | ||||||
| Jun 2, 2021 | ||||||
| Mar 2, 2021 | ||||||
| Nov 19, 2020 | ||||||
| Aug 26, 2020 | ||||||
| May 27, 2020 | ||||||
| Feb 26, 2020 | ||||||
| Nov 25, 2019 | ||||||
| Aug 29, 2019 | ||||||
| May 30, 2019 | ||||||
| Feb 20, 2019 | ||||||
| Nov 15, 2018 | ||||||
| Aug 29, 2018 | ||||||
| May 31, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 14, 2017 | ||||||
| Aug 29, 2017 | ||||||
| May 24, 2017 | ||||||
| Feb 26, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Aug 25, 2016 | ||||||
| May 9, 2016 | ||||||
| Feb 16, 2016 | ||||||
| Dec 16, 2015 | ||||||
| Aug 17, 2015 | ||||||
| Mar 31, 2015 | ||||||
| Feb 12, 2015 | ||||||
| Sep 30, 2014 | ||||||
| Aug 26, 2014 | ||||||